HealthEquity Inc. (NASDAQ:HQY) CEO Jon Kessler sold 54,712 shares of the stock in a transaction that occurred on Tuesday, September 20th. The shares were sold at an average price of $35.07, for a total value of $1,918,749.84. Following the transaction, the chief executive officer now directly owns 485,288 shares of the company’s stock, valued at $17,019,050.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Jon Kessler also recently made the following trade(s):

  • On Monday, September 19th, Jon Kessler sold 65,288 shares of HealthEquity stock. The shares were sold at an average price of $35.02, for a total value of $2,286,385.76.
  • On Thursday, September 15th, Jon Kessler sold 20,000 shares of HealthEquity stock. The shares were sold at an average price of $33.46, for a total value of $669,200.00.
  • On Monday, September 12th, Jon Kessler sold 120,117 shares of HealthEquity stock. The shares were sold at an average price of $33.10, for a total value of $3,975,872.70.
  • On Wednesday, August 31st, Jon Kessler sold 34,883 shares of HealthEquity stock. The shares were sold at an average price of $33.00, for a total value of $1,151,139.00.
  • On Monday, July 25th, Jon Kessler sold 10,000 shares of HealthEquity stock. The shares were sold at an average price of $29.62, for a total value of $296,200.00.
  • On Friday, July 15th, Jon Kessler sold 10,000 shares of HealthEquity stock. The shares were sold at an average price of $30.05, for a total value of $300,500.00.
  • On Thursday, June 23rd, Jon Kessler sold 10,000 shares of HealthEquity stock. The shares were sold at an average price of $29.00, for a total value of $290,000.00.

Shares of HealthEquity Inc. (NASDAQ:HQY) traded up 2.12% during midday trading on Wednesday, hitting $36.20. The stock had a trading volume of 849,136 shares. HealthEquity Inc. has a 52-week low of $15.80 and a 52-week high of $36.80. The firm’s 50 day moving average price is $31.56 and its 200 day moving average price is $27.76. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of 92.82 and a beta of 1.65.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/insider-selling-healthequity-inc-hqy-ceo-sells-54712-shares-of-stock.html

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.03. The firm earned $44.20 million during the quarter. HealthEquity had a net margin of 15.21% and a return on equity of 10.89%. HealthEquity’s revenue for the quarter was up 44.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.08 EPS. On average, equities research analysts expect that HealthEquity Inc. will post $0.51 earnings per share for the current year.

A number of equities analysts recently commented on HQY shares. Raymond James Financial Inc. increased their price target on HealthEquity from $32.00 to $40.00 and gave the company an “outperform” rating in a research note on Monday, September 12th. Wells Fargo & Co. reissued a “buy” rating on shares of HealthEquity in a research note on Wednesday, June 22nd. SunTrust Banks Inc. raised their price objective on HealthEquity from $34.00 to $40.00 and gave the company a “buy” rating in a research note on Wednesday, June 8th. TheStreet raised HealthEquity from a “sell” rating to a “hold” rating in a research note on Tuesday, June 7th. Finally, Zacks Investment Research lowered HealthEquity from a “buy” rating to a “hold” rating in a research note on Tuesday, June 14th. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $36.00.

Large investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in shares of HealthEquity by 56.5% in the second quarter. BlackRock Inc. now owns 3,594 shares of the company’s stock worth $109,000 after buying an additional 1,297 shares during the last quarter. PineBridge Investments L.P. increased its stake in shares of HealthEquity by 4.3% in the second quarter. PineBridge Investments L.P. now owns 4,482 shares of the company’s stock worth $137,000 after buying an additional 186 shares during the last quarter. Teacher Retirement System of Texas increased its stake in shares of HealthEquity by 43.9% in the second quarter. Teacher Retirement System of Texas now owns 6,061 shares of the company’s stock worth $184,000 after buying an additional 1,850 shares during the last quarter. Denver Investment Advisors LLC purchased a new stake in shares of HealthEquity during the second quarter worth approximately $203,000. Finally, Mason Street Advisors LLC purchased a new stake in shares of HealthEquity during the second quarter worth approximately $210,000. Hedge funds and other institutional investors own 91.41% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.